MRK Merck & Company, Inc. Common Stock (new)

NYSE · US · Healthcare · Drug Manufacturers - General · merck.com

139.86USD-3.08%Mkt Cap: 356.01B $P/E: 116.37Today

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxi…

Industry Peers

Drug Manufacturers - General

Screen all

LLY

Eli Lilly and Company Common Stock

$1.02TUSDP/E 38.4

JNJ

Johnson & Johnson Common Stock

$617.01BUSDP/E 29.7

ABBV

AbbVie Inc. Common Stock

Novartis AG Common Stock

AstraZeneca PLC Ordinary Shares

Amgen Inc. - Common Stock

Gilead Sciences, Inc. - Common Stock

$179.47BUSD

NVO

Novo Nordisk A/S Common Stock

$164.79BUSDP/E 9.4

PFE

Pfizer, Inc. Common Stock

$158.45BUSDP/E 36.6

BMY

Bristol-Myers Squibb Company Common Stock

$124.91BUSDP/E 13.5

SNY

Sanofi - American Depositary Shares

$95.65BUSDP/E 21.8

GSK

GSK plc American Depositary Shares (Each representing two Ordinary Shares)

Bayer Aktiengesellschaft

$46.94BUSD

Key Statistics

Company

Market Cap356.01B USD

Enterprise Value402.83B USD

Revenue (TTM)66.57B USD

Gross Profit48.63B USD

Net Income (TTM)18.25B USD

Revenue/Share26.85 USD

Last Price139.86 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees73.0K

CountryUS

SectorHealthcare

IndustryDrug Manufacturers - General

ISIN—

Valuation

P/E (Trailing)116.37

P/E (Forward)15.21

PEG2.64

EV/EBITDA13.95

EV/Revenue6.05

P/S5.35

P/B8.50

EPS (TTM)1.26

EPS (Forward)9.49

52W Range

78.4078% of range156.92

52W High156.92 USD

52W Low78.40 USD

Profitability

Gross Margin74.80%

Oper. Margin-0.24%

EBITDA Margin43.37%

Profit Margin28.08%

ROE34.70%

ROA13.34%

Growth

Revenue Growth5.10%

Earnings Growth—

Cash Flow & Leverage

Operating CF16.47B USD

CapEx (TTM)4.11B USD

FCF Margin22.79%

FCF Yield4.26%

Net Debt46.77B USD

Net Debt/EBITDA1.62

Balance Sheet

Debt/Equity0.94

Current Ratio1.32

Quick Ratio0.74

Book Value/Sh16.99 USD

Cash/Share2.89 USD

Dividends

Fwd Div Rate3.40 USD

Trail. Div Rate3.32 USD

Div. Yield2.36%

5Y Avg Yield2.89%

Payout Ratio266.67%

Ex-Div DateSep 15, 2026

Pay DateOct 7, 2026

Splits

Last Split1048:1000

Split DateJun 3, 2021

Analyst Consensus

Rating1.8 (Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)155.76 USD

Upside (mean)+11.4%

Target Range105.00 USD – 186.00 USD

105.00+11.4% to mean186.00

# Analysts25

Ownership

Shares Out.2.47B

Float2.46B

Insiders0.06%

Institutions83.04%

Short Interest

Short Ratio3.1d

Short % Float1.40%

Short % Out.1.40%

Shares Short34.43M

Short (prev mo.)24.51M

Technical

SMA 50142.29 (-1.7%)

SMA 200122.86 (+13.8%)

Beta0.23

S&P 52W Chg14.58%

Avg Vol (30d)9.45M

Avg Vol (10d)9.11M

Technical Indicators

RSI (14)46.6

MACD0.8656

MACD Signal1.7800

MACD Hist.-0.9143

BB Upper151.61 USD

BB Middle146.96 USD

BB Lower142.32 USD

BB Width6.32%

ATR (14)3.358 USD

Vol Ratio (20d)0.81x